Found: 11
Select item for more details and to access through your institution.
An integrative systems biology approach for precision medicine in diabetic kidney disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, p. 6, doi. 10.1111/dom.13416
- By:
- Publication type:
- Article
Inferring Direct Regulatory Targets of a Transcription Factor in the DREAM2 Challenge.
- Published in:
- Annals of the New York Academy of Sciences, 2009, v. 1158, p. 215, doi. 10.1111/j.1749-6632.2008.03759.x
- By:
- Publication type:
- Article
Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channel.
- Published in:
- Human Molecular Genetics, 2013, v. 22, n. 15, p. 3038, doi. 10.1093/hmg/ddt160
- By:
- Publication type:
- Article
Comprehensive Cross-Population Analysis of High-Grade Serous Ovarian Cancer Supports No More Than Three Subtypes.
- Published in:
- G3: Genes | Genomes | Genetics, 2016, v. 6, n. 12, p. 4097, doi. 10.1534/g3.116.033514
- By:
- Publication type:
- Article
Cobimetinib Alone and Plus Venetoclax With/Without Atezolizumab in Patients With Relapsed/Refractory Multiple Myeloma.
- Published in:
- 2023
- By:
- Publication type:
- journal article
P-071: Multi-omic analysis of the tumor microenvironment reveals novel associations in a clinical trial of atezolizumab ± daratumumab for relapsed/refractory multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S78, doi. 10.1016/S2152-2650(21)02205-9
- By:
- Publication type:
- Article
Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 10, p. 1, doi. 10.1093/jnci/dju249
- By:
- Publication type:
- Article
Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 10, p. 1, doi. 10.1093/jnci/dju249
- By:
- Publication type:
- Article
Dacomitinib, an Irreversible Pan-ErbB Inhibitor Significantly Abrogates Growth in Head and Neck Cancer Models That Exhibit Low Response to Cetuximab.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0056112
- By:
- Publication type:
- Article
Identification of Novel Targets of CSL-Dependent Notch Signaling in Hematopoiesis.
- Published in:
- PLoS ONE, 2011, v. 6, n. 5, p. 1, doi. 10.1371/journal.pone.0020022
- By:
- Publication type:
- Article
Multi-omic analysis of the tumor microenvironment shows clinical correlations in Ph1 study of atezolizumab +/- SoC in MM.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1085893
- By:
- Publication type:
- Article